Novonix (NVX) Total Liabilities (2020 - 2025)

Novonix's Total Liabilities history spans 6 years, with the latest figure at $121.2 million for Q4 2025.

  • For Q4 2025, Total Liabilities rose 37.0% year-over-year to $121.2 million; the TTM value through Dec 2025 reached $121.2 million, up 37.0%, while the annual FY2025 figure was $121.2 million, 37.0% up from the prior year.
  • Total Liabilities reached $121.2 million in Q4 2025 per NVX's latest filing, up from $88.5 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $121.2 million in Q4 2025 to a low of $14.2 million in Q2 2021.
  • Average Total Liabilities over 5 years is $68.1 million, with a median of $66.6 million recorded in 2022.
  • Peak YoY movement for Total Liabilities: soared 278.97% in 2022, then rose 11.46% in 2024.
  • A 5-year view of Total Liabilities shows it stood at $14.2 million in 2021, then soared by 261.33% to $51.4 million in 2022, then surged by 54.58% to $79.4 million in 2023, then rose by 11.46% to $88.5 million in 2024, then surged by 37.0% to $121.2 million in 2025.
  • Per Business Quant, the three most recent readings for NVX's Total Liabilities are $121.2 million (Q4 2025), $88.5 million (Q4 2024), and $79.4 million (Q4 2023).